Back to search

Italy· 041799038

IXED*1 flaconcino EV 1.000 Unita' Internazionali + 1 flaconcino solv 10 ml + set infusionale

A medicinal product containing fattore ix di coagulazione del sangue umano, registered in Italy by KEDRION SpA, on the national reimbursement list.

Reimbursed in Italy (AIFA class A)

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · ITPublic registernormalisedIXED*1 flaconcino EV 1.000 Unita' Int…ATC—REGISTER NO.041799038PACKS LISTED1CHECKEDJune 4, 2026

The record

At a glance

Active substance
Fattore IX di coagulazione del sangue umano
Manufacturer
KEDRION SpA
Country
Italy (IT)
ATC code
—
Reimbursed
Yes
Last checked
June 4, 2026

Packs & prices · 1

1 priced
  • aic
    041799038
    IXED*1 flaconcino EV 1.000 Unita' Internazionali + 1 flaconcino solv 10 ml + set infusionale
    EUR 676.2

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ef494818-f700-424c-a316-a90dc6c0cf4a
GET /v1/drugs/ef494818-f700-424c-a316-a90dc6c0cf4a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "price": 676.2,
  "source": "aifa",
  "currency": "EUR",
  "strength": "FATTORE IX DI COAGULAZIONE UMANO LIOFILIZZATO 1.000UI 10ML 1 UNITA' USO PARENTERALE",
  "substance": "Fattore IX di coagulazione del sangue umano",
  "equivalence_group": "LJB",
  "transparency_flag": null
}

See everything about fattore ix di coagulazione del sangue umano.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.